| HGNC Family | Immunoglobulin superfamily domain containing |
| Name | opioid binding protein/cell adhesion molecule-like |
| Description | This gene encodes a member of the IgLON subfamily in the immunoglobulin protein superfamily of proteins. The encoded preprotein is proteolytically processed to generate the mature protein. This protein is localized in the plasma membrane and may have an accessory role in opioid receptor function. This gene has an ortholog in rat and bovine. The opioid binding-cell adhesion molecule encoded by the rat gene binds opioid alkaloids in the presence of acidic lipids, exhibits selectivity for mu ligands and acts as a GPI-anchored protein. Since the encoded protein is highly conserved in species during evolution, it may have a fundamental role in mammalian systems. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Jan 2016] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nOPCML (opioid binding protein/cell adhesion molecule‐like) is a glycosylphosphatidylinositol (GPI)–anchored member of the IgLON family that functions principally as a tumor suppressor. Initial studies in epithelial ovarian cancer revealed that OPCML is frequently inactivated by allele loss and CpG island hypermethylation, strongly implicating it as a candidate tumor suppressor gene in this malignancy."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "6"}]}, {"type": "t", "text": " Moreover, similar epigenetic inactivation of OPCML has been reported across several tumor types, including nasopharyngeal, bladder, gastric, and cholangiocarcinoma, underscoring its importance in cancer biology.\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nMechanistically, OPCML exerts its tumor‐suppressive effects by directly interacting with and negatively regulating a specific repertoire of receptor tyrosine kinases (RTKs) such as EPHA2, FGFR1, FGFR3, HER2, HER4, and AXL. By binding to the extracellular domains of these RTKs, OPCML alters their trafficking—shifting them into non–clathrin‐dependent endocytic pathways—and promotes their polyubiquitination and subsequent proteasomal degradation. This targeting not only attenuates downstream oncogenic signaling but also interferes with the formation of heterodimers, as seen with HER2 and EGFR, thereby reducing sustained mitogenic signals."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "7", "end_ref": "10"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its mechanistic role in RTK regulation, OPCML’s frequently aberrant promoter methylation also positions it as a promising diagnostic and prognostic biomarker in cancer. Quantitative methylation analyses of OPCML have revealed that elevated promoter methylation correlates with tumor progression and poorer outcomes in cancers such as bladder carcinoma, prostate cancer, gastric carcinoma, and cholangiocarcinoma. Interestingly, OPCML expression is not restricted to peripheral tissues; in the central nervous system it participates in the regulation of synaptic function. Disruption of OPCML in neural tissues has been associated with altered spine maturation and cognitive deficits, lending support to its emerging connection with neuropsychiatric disorders such as schizophrenia."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "11", "end_ref": "16"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its role as a biomarker, the restoration or exogenous administration of OPCML has therapeutic potential. Experimental studies demonstrate that recombinant OPCML protein can inhibit tumor cell proliferation in vitro and reduce tumor growth in in vivo models, largely by reinstating the negative regulation of RTK signaling. Furthermore, high OPCML expression appears to sensitize cancer cells to RTK inhibitors such as lapatinib and erlotinib, suggesting that OPCML-based co-therapy might overcome resistance to these agents. These findings broaden the therapeutic window of OPCML by highlighting its dual role in modulating oncogenic signaling and serving as a treatment-sensitizing factor—a strategy that may be applicable not only in ovarian and breast cancers but also in cholangiocarcinoma and other malignancies."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "17", "end_ref": "23"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Grant C Sellar, Karen P Watt, Genevieve J Rabiasz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng1183"}], "href": "https://doi.org/10.1038/ng1183"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12819783"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12819783"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Fang C Mei, Travis W Young, Jinsong Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "RAS-mediated epigenetic inactivation of OPCML in oncogenic transformation of human ovarian surface epithelial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FASEB J (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1096/fj.05-4586fje"}], "href": "https://doi.org/10.1096/fj.05-4586fje"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16384911"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16384911"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Long Wang, Jin-Shui Zhu, Ming-Quan Song, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Comparison of gene expression profiles between primary tumor and metastatic lesions in gastric cancer patients using laser microdissection and cDNA microarray."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "World J Gastroenterol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3748/wjg.v12.i43.6949"}], "href": "https://doi.org/10.3748/wjg.v12.i43.6949"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17109515"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17109515"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Artur Czekierdowski, Sylwia Czekierdowska, Marek Szymanski, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Opioid-binding protein/cell adhesion molecule-like (OPCML) gene and promoter methylation status in women with ovarian cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuro Endocrinol Lett (2006)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17159813"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17159813"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "J E Reed, J R Dunn, D G du Plessis, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of cellular adhesion molecule 'OPCML' is down-regulated in gliomas and other brain tumours."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neuropathol Appl Neurobiol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1365-2990.2006.00786.x"}], "href": "https://doi.org/10.1111/j.1365-2990.2006.00786.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17239010"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17239010"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Jeffrey A Tsou, Janice S Galler, Kimberly D Siegmund, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of a panel of sensitive and specific DNA methylation markers for lung adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1476-4598-6-70"}], "href": "https://doi.org/10.1186/1476-4598-6-70"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17967182"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17967182"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Yan Cui, Ying Ying, Andrew van Hasselt, et al. "}, {"type": "b", "children": [{"type": "t", "text": "OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0002990"}], "href": "https://doi.org/10.1371/journal.pone.0002990"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18714356"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18714356"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Sara Duarte-Pereira, Filipa Paiva, Vera Lúcia Costa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prognostic value of opioid binding protein/cell adhesion molecule-like promoter methylation in bladder carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Cancer (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ejca.2010.12.025"}], "href": "https://doi.org/10.1016/j.ejca.2010.12.025"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21273058"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21273058"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Benjaporn Panichareon, Kazuhiro Nakayama, Wanpen Thurakitwannakarn, et al. "}, {"type": "b", "children": [{"type": "t", "text": "OPCML gene as a schizophrenia susceptibility locus in Thai population."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Neurosci (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12031-011-9595-2"}], "href": "https://doi.org/10.1007/s12031-011-9595-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21833655"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21833655"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Arthur B McKie, Sebastian Vaughan, Elisa Zanini, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The OPCML tumor suppressor functions as a cell surface repressor-adaptor, negatively regulating receptor tyrosine kinases in epithelial ovarian cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Discov (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/2159-8290.CD-11-0256"}], "href": "https://doi.org/10.1158/2159-8290.CD-11-0256"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22585860"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22585860"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Maoqing Ye, Fabienne Parente, Xiaodong Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Gene-targeted deletion of OPCML and Neurotrimin in mice does not yield congenital heart defects."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Med Genet A (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ajmg.a.36441"}], "href": "https://doi.org/10.1002/ajmg.a.36441"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24616287"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24616287"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Yu Wu, Jerry Davison, Xiaoyu Qu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Methylation profiling identified novel differentially methylated markers including OPCML and FLRT2 in prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Epigenetics (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/15592294.2016.1148867"}], "href": "https://doi.org/10.1080/15592294.2016.1148867"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26890304"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26890304"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "L H Wang, F F Chu, D H Ren, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Effect of OPCML gene on the biological behavior of gastric cancer cell line AGS."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Regul Homeost Agents (2016)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27358143"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27358143"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Xiangbin Xing, Weibin Cai, Sanmei Ma, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Down-regulated expression of OPCML predicts an unfavorable prognosis and promotes disease progression in human gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12885-017-3203-y"}], "href": "https://doi.org/10.1186/s12885-017-3203-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28407749"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28407749"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Elisa Zanini, Louay S Louis, Jane Antony, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The Tumor-Suppressor Protein OPCML Potentiates Anti-EGFR- and Anti-HER2-Targeted Therapy in HER2-Positive Ovarian and Breast Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Ther (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1535-7163.MCT-17-0081"}], "href": "https://doi.org/10.1158/1535-7163.MCT-17-0081"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28775148"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28775148"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Jane Antony, Elisa Zanini, Zoe Kelly, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EMBO Rep (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.15252/embr.201745670"}], "href": "https://doi.org/10.15252/embr.201745670"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29907679"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29907679"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Isidora Simovic, Natalia Castaño-Rodríguez, Nadeem O Kaakoush "}, {"type": "b", "children": [{"type": "t", "text": "OPCML: A Promising Biomarker and Therapeutic Avenue."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Trends Cancer (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.trecan.2019.06.002"}], "href": "https://doi.org/10.1016/j.trecan.2019.06.002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31421903"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31421903"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Zhengrong Zhang, Maoqing Ye, Qiongwei Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The Schizophrenia Susceptibility Gene OPCML Regulates Spine Maturation and Cognitive Behaviors through Eph-Cofilin Signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Rep (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.celrep.2019.08.091"}], "href": "https://doi.org/10.1016/j.celrep.2019.08.091"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31577955"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31577955"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Xiaohe Fang, Yong Dong, Ruilin Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LINC00619 restricts gastric cancer progression by preventing microRNA-224-5p-mediated inhibition of OPCML."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arch Biochem Biophys (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.abb.2020.108390"}], "href": "https://doi.org/10.1016/j.abb.2020.108390"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32359894"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32359894"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Jane Antony, Elisa Zanini, James R Birtley, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Emerging roles for the GPI-anchored tumor suppressor OPCML in cancers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Gene Ther (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41417-020-0187-6"}], "href": "https://doi.org/10.1038/s41417-020-0187-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32595215"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32595215"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Bin Lian, Hong Li, Yaobang Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression and promoter methylation status of OPCML and its functions in the inhibition of cell proliferation, migration, and invasion in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Breast Cancer (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12282-020-01179-9"}], "href": "https://doi.org/10.1007/s12282-020-01179-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33108608"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33108608"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Ricuphan Khamko, Jureerut Daduang, Chatri Settasatian, et al. "}, {"type": "b", "children": [{"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "OPCML"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " Exerts Antitumor Effects in Cholangiocarcinoma "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "via"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " AXL/STAT3 Inactivation and Rho GTPase Down-regulation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Genomics Proteomics (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.21873/cgp.20296"}], "href": "https://doi.org/10.21873/cgp.20296"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34697068"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34697068"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Ricuphan Khamko, Wiphawan Wasenang, Jureerut Daduang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Combined OPCML and AXL Expression as a Prognostic Marker and OPCML Enhances AXL Inhibitor in Cholangiocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "In Vivo (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.21873/invivo.12816"}], "href": "https://doi.org/10.21873/invivo.12816"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35478117"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35478117"}]}]}]}
|
| Synonyms | IGLON1, OBCAM, OPCM |
| Proteins | OPCM_HUMAN |
| NCBI Gene ID | 4978 |
| API | |
| Download Associations | |
| Predicted Functions |
 |
| Co-expressed Genes |
|
| Expression in Tissues and Cell Lines |
|
OPCML has 4,557 functional associations with biological entities spanning 9 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 96 datasets.
Click the + buttons to view associations for OPCML from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of OPCML gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of OPCML gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of OPCML gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of OPCML gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of OPCML gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of OPCML gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of OPCML gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of OPCML gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of OPCML gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of OPCML gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with OPCML gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of OPCML gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of OPCML gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of OPCML gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of OPCML gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing OPCML protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with OPCML protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with OPCML protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of OPCML gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with OPCML gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with OPCML gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with OPCML gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| dbGAP Gene-Trait Associations | traits associated with OPCML gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by OPCML gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores 2025 | diseases involving OPCML gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with OPCML gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with OPCML gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with OPCML gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with OPCML gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with OPCML gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at OPCML gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of OPCML gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of OPCML gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing OPCML from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with OPCML gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with OPCML gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of OPCML gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with OPCML gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing OPCML from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of OPCML gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of OPCML gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of OPCML gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of OPCML gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of OPCML gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of OPCML gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving OPCML gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing OPCML protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of OPCML gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of OPCML gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of OPCML gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of OPCML gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of OPCML gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations | phenotypes associated with OPCML gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with OPCML gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with OPCML gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of OPCML gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of OPCML gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of OPCML gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for OPCML from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with OPCML gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with OPCML gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by OPCML gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for OPCML protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of OPCML gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of OPCML gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of OPCML gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of OPCML gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of OPCML gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of OPCML gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing OPCML protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain OPCML protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by OPCML gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of OPCML gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MSigDB Cancer Gene Co-expression Modules | co-expressed genes for OPCML from the MSigDB Cancer Gene Co-expression Modules dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of OPCML gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of OPCML gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| OMIM Gene-Disease Associations | phenotypes associated with OPCML gene from the curated OMIM Gene-Disease Associations dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for OPCML from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of OPCML gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of OPCML gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| Reactome Pathways 2024 | pathways involving OPCML protein from the Reactome Pathways 2024 dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of OPCML gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at OPCML gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of OPCML gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of OPCML gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| SynGO Synaptic Gene Annotations | synaptic terms associated with OPCML gene from the SynGO Synaptic Gene Annotations dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of OPCML gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of OPCML gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of OPCML gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of OPCML gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of OPCML protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of OPCML protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of OPCML protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of OPCML protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with OPCML protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with OPCML protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
